Skip to content

AESTHETIXSURG: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AESTHETIXSURG

BE 1016.422.220
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€10,105
2024 · -€12,937+€23,042
Equity
-€2,732
2024 · -€12,837+€10,105
Cash
€6,590
2024 · €5,490+€1,100
Balance sheet total
€17,954
2024 · €5,870+€12,084

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€6,570

    new in 2025: €6,570

  • Receivables within one year +€3,218

    up €3,218 (+847%), from €380 to €3,599

    of which Other amounts receivable: +€3,313

  • Deferred charges and accrued income +€1,196

    new in 2025: €1,196

  • Cash +€1,100

    up €1,100 (+20.0%), from €5,490 to €6,590

    mainly Net result for the year (+€10,105) and Other debts (+€1,939)

Equity and liabilities
  • Profit (loss) carried forward +€10,105

    up €10,105 (+78.1%), from -€12,937 to -€2,832

  • Other debts +€1,939

    up €1,939 (+10.4%), from €18,707 to €20,646

Income statement
  • Gross operating margin +€23,792

    up €23,792, from -€12,937 to €10,855

  • Taxes +€402

    new in 2025: €402

  • Depreciation +€292

    new in 2025: €292

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€12,937
Gross operating margin +€23,792
Depreciation -€292
Financial income +€0
Financial charges -€57
Taxes -€402
Result 2025 €10,105
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€7,962
Investment -€6,862
Financing €0
Cash 2024 €5,490
Net result for the year +€10,105
Depreciation +€292
Receivables within one year -€3,218
Deferred charges and accrued income -€1,196
Trade debts +€40
Other debts +€1,939
Investment in fixed assets (net) -€6,862
Cash 2025 €6,590
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,870 €17,954 +€12,084 +206%
Fixed assets 21/28 - €6,570 +€6,570
Tangible fixed assets 22/27 - €6,570 +€6,570
Other tangible fixed assets 26 - €6,570 +€6,570
Current assets 29/58 €5,870 €11,384 +€5,514 +93.9%
Amounts receivable within one year 40/41 €380 €3,599 +€3,218 +847%
Trade receivables 40 €95 - -€95
Other amounts receivable 41 €285 €3,599 +€3,313 +1,161%
Cash at bank and in hand 54/58 €5,490 €6,590 +€1,100 +20.0%
Deferred charges and accrued income 490/1 - €1,196 +€1,196
Total equity and liabilities 10/49 €5,870 €17,954 +€12,084 +206%
Equity 10/15 -€12,837 -€2,732 +€10,105 +78.7%
Contributions 10/11 €100 €100 = 0.0%
Profit (loss) carried forward 14 -€12,937 -€2,832 +€10,105 +78.1%
Amounts payable 17/49 €18,707 €20,686 +€1,979 +10.6%
Amounts payable within one year 42/48 €18,707 €20,686 +€1,979 +10.6%
Trade debts 44 - €40 +€40
Suppliers 440/4 - €40 +€40
Other amounts payable 47/48 €18,707 €20,646 +€1,939 +10.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €292 +€292
Gross operating margin 9900 -€12,937 €10,855 +€23,792
Operating profit (loss) 9901 -€12,937 €10,563 +€23,500
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B - €57 +€57
Recurring financial charges 65 - €57 +€57
Profit (loss) for the period before taxes 9903 -€12,937 €10,507 +€23,443
Income taxes 67/77 - €402 +€402
Profit (loss) for the period 9904 -€12,937 €10,105 +€23,042
Profit (loss) for the period to be appropriated 9905 -€12,937 €10,105 +€23,042

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.